Lindbrook Capital’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Lindbrook Capital's HALO Position: Q1 2025 in Review
Lindbrook Capital increased its Halozyme (HALO) stake by 9.7% in Q1 2025, buying an estimated $7.2K and bringing the position to 1,405 shares worth $89.7K. The position accounts for 0.01% of the portfolio, ranked #723.
Lindbrook Capital first reported a position in HALO in Q4 2018 and has held it in 21 quarters since. The position peaked at $132K in Q4 2021. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.
- Lindbrook Capital held 1,405 shares of Halozyme worth $89.7K as of Q1 2025.
- Lindbrook Capital bought 124 Halozyme shares in Q1 2025, an estimated $7.2K.
- Halozyme made up 0.01% of Lindbrook Capital's portfolio in Q1 2025, its #723 holding.
- Lindbrook Capital first reported a position in Halozyme in Q4 2018 and has held it in 21 quarters since.
- Lindbrook Capital's Halozyme position peaked at $132K in Q4 2021.
- 550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.
Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.